Survival Benefit of Intervention Treatment in Advanced Anaplastic Thyroid Cancer

Figure 2

One hundred five ATC patients were classified, among whom 49 received palliative modality and 56 patients received interventional treatment. Intervention treatment allowed a median survival time of 110 days (95% CI: 84–140) that was better than palliative treatment. Palliative treatment allowed a median survival time of 58 days (95% CI: 38–74). Furthermore, the Kaplan-Meier survival curve was analyzed using the log-rank test, revealing that interventional treatment was significantly better than palliative treatment () (a). In the interventional treatment, the combination of surgery with postoperative chemoradiation showed the best survival rate (log-rank test; ). The median survival time for interventional modalities was analyzed by subgroup and showed times of 187 days (95% CI: 84–208) in the surgery combined with postoperative chemoradiation treatment, 177 days (95% CI: 86–337) in the surgery combined with radiation treatment, 133 days (95% CI: 52–192) in the chemoradiation treatment, and 64 days (95% CI: 43–96) in the surgery-alone treatment (b).

(a)

(b)